Industry Insights

31. Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP 9/1/2025

    In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.

32. The Resurgence Of Antibody-Drug Conjugates 9/1/2025

    As advancements in ADC technology and clinical trial methodologies progress, Antibody-Drug Conjugates (ADCs) are poised to become pivotal in precision oncology.

33. Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies 8/29/2025

    Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

34. Optimizing Global Early-Phase Oncology Trials 8/29/2025

    By integrating strong partnerships, local expertise, and predictive analytics, sponsors and CROs can identify and activate the most suitable sites, accelerating trial delivery.

35. 3 Quick Takes From A PI With 100+ Trials To His Name 8/29/2025

    Principal investigator Norman B. Gaylis, MD, shares his perspective on patient recruitment, protocol design, and vendor selection.

36. Alzheimer's Trial Targeting Amyloid Beta Oligomers Sees Cost Savings, Patient Satisfaction With New Screening 8/29/2025

    Acumen Pharmaceuticals' Eric Siemers, MD, discusses their novel Alzheimer's disease screening method and trial design for investigational drug sabirnetug that keeps both the clinical site and patient experience in mind. 

37. Insuring Global Clinical Trials: Navigating Risks Across Borders 8/28/2025

    Foreign clinical trials insurance is indispensable. Learn its features, its benefits, and why it's needed.

38. Clinical Safety Services In FSP Models 8/27/2025

    Selecting the right functional service provider (FSP) for safety services is fundamental to protecting patients and requires a resilient, strategic partnership that enhances trial integrity and outcomes.

39. Navigating The Complexities Of Planning And Executing Multiregional Clinical Trials 8/27/2025

    Plan your first overseas study or expand an established pipeline; with the help of strategic insights to navigate complexities, maximize investment, and position new therapies for international success.

40. Why New Zealand Is Emerging As A Clinical Trial Hub 8/27/2025

    New Zealand is rapidly emerging as a premier destination for clinical research, offering a unique combination of regulatory agility, scientific expertise, and cost efficiency.